Renal thromboxane excretion in Brattleboro rats with hereditary hypothalamic diabetes insipidus. Effect of vasopressin treatment.
Rats with hereditary hypothalamic diabetes insipidus (Brattleboro strain) which are devoid of vasopressin, excrete significantly increased amounts of immunoreactive thromboxane B2 in urine. The increase was corrected by treatment with vasopressin. These results suggest that, in the intact organism, thromboxane synthesis may be under tonic inhibitory control by vasopressin although other renal mechanisms explaining the increase in thromboxane cannot be excluded. Our observations further support an involvement of prostaglandins and thromboxanes in the regulation of water metabolism.
D000818:Animals; D001127:Arginine Vasopressin; D003919:Diabetes Insipidus / Q000235:genetics / Q000503:physiopathology*; D007031:Hypothalamus / Q000503:physiopathology*; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology*; D008297:Male; D051381:Rats; D011910:Rats, Brattleboro; D013929:Thromboxane B2 / Q000652:urine*; D013931:Thromboxanes / Q000652:urine*; D014667:Vasopressins / Q000494:pharmacology*
D013931:Thromboxanes; C016671:pitressin tannate; D014667:Vasopressins; D001127:Arginine Vasopressin; D013929:Thromboxane B2